Stanley W. Carson, PharmD, FCCP, BCPP: Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology

Name: Stanley W. Carson, PharmD, FCCP, BCPP: Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology
SKU: 3245
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 36 No. 1 Articles Tags: aliou-d-ousmanou, drug-interactions, drug-transport-protein, inducer, inhibitor, multidrug-resistance, p-glycoprotein, sheri-l-hoyler, stanley-w-carson, substrate

Description

Stanley W. Carson, PharmD, FCCP, BCPP: Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology

Description

Stanley W. Carson

DRUG INTERACTIONS

Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology

Stanley W. Carson, PharmD, FCCP, BCPP, Aliou D. Ousmanou, PharmD, and Sheri L. Hoyler, PharmD

Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR

David M. Lyons, PhD: Stress, Depression, and Inherited Variation in Primate Hippocampal and Prefrontal Brain Development

Jay D. Kranzler, MD, PhD: The Psychopharmacology of Fibromyalgia: A Drug Development Perspective

C. Lindsay DeVane, PharmD: Clinical Significance of Drug Binding, Protein Binding, and Binding Displacement Drug Interactions

Stanley W. Carson, PharmD, FCCP, BCPP: Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology

Description

Stanley W. Carson

DRUG INTERACTIONS

Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology

Stanley W. Carson, PharmD, FCCP, BCPP, Aliou D. Ousmanou, PharmD, and Sheri L. Hoyler, PharmD

Related products

Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR

David M. Lyons, PhD: Stress, Depression, and Inherited Variation in Primate Hippocampal and Prefrontal Brain Development

Jay D. Kranzler, MD, PhD: The Psychopharmacology of Fibromyalgia: A Drug Development Perspective

C. Lindsay DeVane, PharmD: Clinical Significance of Drug Binding, Protein Binding, and Binding Displacement Drug Interactions